Serum anti-Müllerian hormone level as a predictor of poor ovarian response in in vitro fertilization patients

Purpose To evaluate the clinical value of day 3 serum anti-Mullerian hormone (AMH) compared with day 3 serum follicle-stimulating hormone (FSH) and human chorionic gonadotropin (hCG) day estradiol (E2) levels and antral follicle count (AFC) in the prediction of poor ovarian response in controlled ovarian hyperstimulation (COH).